F. Grosso

Type de document

Co-auteur

P. Zucali

S. Zai

Y.L. Wu

J.G. Whisenant

H. Wakelee

R. Von Moos

L. Voltolini

G. Viscardi

J. Van Meerbeeck

A. Trama

V. Torri

S. Tissot-Renaud

M. Tiseo

D. Tarussio

E. Stroppa

P. Solli

V. Scotti

M. Schneider

S. Schmid

S. Rusakiewicz

M. Pless

S Peters

A. Passaro

G. Pasello

V. Pancaldi

D. Moro-Sibilot

G. Minuti

O. Michielin

Y. Metaxas

E. Mercadante

J. Mazieres

M. Mark

A. Maconi

S.V. Liu

N. La Verde

L. Kandalaft

S. Intagliata

L.C. Huang

L. Horn

S. Hayoz

F. Grossi

V. Gregorc

R. Giusti

C. Genova

P. Garrido

M.C. Garassino

M. Früh

P. Froesch

G. Finocchiaro

E. Felip

A.M. Dingemans

A. De Toma

J. Dagher

A. Cortellini

C. Chini

G.L. Ceresoli

J. Cadranel

M. Brighenti

E. Bria

A.C. Bettini

R. Berardi

F. Benedetti

F. Barlesi

G. Banna

J. Baena

F. Agustoni

Source

Serveur académique Lausannois (2)

Mot-clé

thérapie (2) Treatment (2) Chemotherapy (2) Ci (Chinese poetry) (2) Therapeutics (2) Patients (2) Mesothelioma (2) Human beings (2) Lungs (2) Chemotherapy (2) Patients (2) puits (1) temps (durée) (1) test (1) tabagisme (1) sécurité (1) risque (1) oncologie (1) mortalité (1) laboratoire (1) infection (1) histoire (1) analyse (1) exposition (1) effet (1) âge (1) méthode (1) cancer (1) taux (1) survie (1)

Documents écrit par F. Grosso (2) | parle de F. Grosso (1)

Long-term benefit of lurbinectedin as palliative chemotherapy in progressive malignant pleural mesothelioma (MPM): final efficacy and translational data of the SAKK 17/16 study.

M. Mark et al.

COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study.

M.C. Garassino et al.